Healthcare costs of a consecutive cohort of patients with Ulcerative Colitis and Crohn’s disease treated at a Tertiary Medical Center in Israel Academic Article uri icon


  • OBJECTIVES Up-to-date estimation of healthcare costs in Ulcerative Colitis (UC) and Crohn's Disease (CD) patients is crucial to inform budgeting and resource allocation decisions. Recent introduction of biologic therapies rendered previous cost studies with standard therapy obsolete. We sought to determine healthcare costs in a consecutive sample of real-world UC and CD patients managed in a specialized facility in a tertiary referral center in Israel. METHODS Data-bases of patients enrolled in an ongoing socio- economic study were mined to determine healthcare resource utilization during the years 2012 and 2013. This included direct charges for in-patients and out-patients, hospitalizations, investigations and medical and surgical treatments. Prices were obtained from the Ministry of Health Tariff (12/2014) and expressed as US $. Data express costs …

publication date

  • January 1, 2015